DD Q1 2026 Earnings Call Summary

DuPont Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Net Sales: $1.7 billion, up 4% year-over-year, driven by 2% organic growth and a 2% currency benefit.
Operating EBITDA: $414 million, a 15% increase year-over-year, resulting in a margin of 24.6%, up 230 basis points.
Adjusted EPS: $0.55, reflecting a 53% year-over-year increase; on a pro forma basis, up 20%.
Free Cash Flow: $147 million, with a conversion rate of 65%.
Segment Performance:
- Healthcare & Water Technologies: Sales of $806 million, up 6% (3% organic growth).
- Diversified Industrials: Sales of $875 million, up 3% (flat organic growth).

2. Strategic Updates and Business Highlights

Divestiture: Completed the sale of the Aramids business on April 1, contributing to improved cash flow and capital allocation.
Sustainability Goals: Released the 2026 sustainability report and set new 2035 goals focusing on sustainable innovation and operational resilience.
Innovation: Continued investment in R&D and digital capabilities, with new product launches in healthcare and water technologies.
Operational Improvements: Focus on productivity and reliability, with significant enhancements in asset performance and delivery.

3. Forward Guidance and Outlook

Full Year 2026 Guidance:
- Net sales expected to be approximately $7.185 billion, reflecting a 4% organic growth assumption.
- Operating EBITDA projected at $1.745 billion.
- Adjusted EPS guidance raised to $2.35 - $2.40 per share.
Q2 2026 Estimates:
- Net sales of about $1.8 billion, operating EBITDA of about $430 million, and adjusted EPS of $0.59.
- Anticipated organic growth of 3% year-over-year.

4. Bad News, Challenges, or Points of Concern

Middle East Conflict: Ongoing logistics disruptions impacted water business sales, with an estimated $10 million loss in Q1. Future sales may still be affected if the conflict continues.
Construction Market Weakness: Continued softness in construction markets, particularly in North America, with expectations of flat growth for the year.
Stranded Costs: Approximately $30 million in stranded costs expected, with only $10 million targeted for removal in the first year.
Pricing Pressures: Anticipated raw material inflation and the need for price increases to maintain margins, particularly in the second half of the year.

5. Notable Q&A Insights

80/20 Strategy: Implementation is ongoing within Diversified Industrials, with expected long-term margin improvements but minimal immediate top-line impact.
Water Business: Despite Q1 challenges, management remains optimistic about recovery and project timing, expecting mid-single-digit growth for the full year.
Healthcare Growth: Strong demand driven by aging populations and increased healthcare access, with expectations for continued growth in medical packaging and biopharma.
Pricing Strategy: The company has implemented surcharges and price increases to offset rising costs, with a focus on maintaining constructive customer relationships.
M&A Potential: Management remains open to strategic acquisitions to enhance growth, particularly in healthcare, leveraging proceeds from the Aramids divestiture.

Overall, DuPont reported a strong start to 2026, with solid financial performance and strategic initiatives aimed at long-term growth, despite facing challenges from geopolitical tensions and market softness in certain sectors.

DD — DuPont de Nemours, Inc.